| scholarly article | Q13442814 |
| P2093 | author name string | Wei Chen | |
| H Kim Lyerly | |||
| Jiangbo Wang | |||
| Larry S Barak | |||
| Xiu-Rong Ren | |||
| Robert A Mook | |||
| Hailan Piao | |||
| P2860 | cites work | Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia | Q24290495 |
| Comprehensive molecular characterization of human colon and rectal cancer | Q24630415 | ||
| Wnt/beta-catenin signaling: components, mechanisms, and diseases | Q24630938 | ||
| Uncouplers of oxidative phosphorylation | Q24670385 | ||
| Wnt/β-catenin signaling and disease | Q26823272 | ||
| Wnt/beta-catenin signaling in development and disease | Q27860784 | ||
| Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4 | Q28205234 | ||
| Mechanism of action of reagents that uncouple oxidative phosphorylation | Q28237551 | ||
| Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase | Q28296225 | ||
| Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway | Q28478466 | ||
| Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects | Q28484821 | ||
| Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus | Q28546591 | ||
| A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected] | Q31106002 | ||
| The anti-helminthic niclosamide inhibits Wnt/Frizzled1 signaling. | Q33505762 | ||
| Fasciolicides: efficacy, actions, resistance and its management | Q33733908 | ||
| Multi-targeted therapy of cancer by niclosamide: A new application for an old drug. | Q34199032 | ||
| Growth inhibition of ovarian tumor-initiating cells by niclosamide. | Q34265703 | ||
| Small molecule modulators of Wnt/β-catenin signaling. | Q34604768 | ||
| Anticancer effects of niclosamide in human glioblastoma. | Q34889036 | ||
| Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice | Q34988375 | ||
| Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations | Q35051128 | ||
| Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer | Q35150756 | ||
| Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production | Q35664315 | ||
| Structure-activity analysis of niclosamide reveals potential role for cytoplasmic pH in control of mammalian target of rapamycin complex 1 (mTORC1) signaling | Q36006981 | ||
| Structure-activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure | Q36454906 | ||
| Mining the Wnt pathway for cancer therapeutics | Q36670448 | ||
| Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer | Q37227498 | ||
| Effect of niclosamide on basal-like breast cancers | Q37695022 | ||
| Discovery of modulators of protein-protein interactions: current approaches and limitations | Q37841619 | ||
| The potential of targeting Wnt/β-catenin in colon cancer | Q38202202 | ||
| Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer | Q39001975 | ||
| Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancer. | Q39003793 | ||
| Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer | Q39522017 | ||
| The biology and toxicology of molluscicides, Bayluscide | Q40254414 | ||
| Mechanism of actin polymerization in cellular ATP depletion | Q40615740 | ||
| Activities of drug combinations against Mycobacterium tuberculosis grown in aerobic and hypoxic acidic conditions | Q41454109 | ||
| Niclosamide Analogs for Treatment of Ovarian Cancer | Q41576087 | ||
| Uncoupling: new approaches to an old problem of bioenergetics | Q41723090 | ||
| New life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing | Q42790739 | ||
| Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species | Q43136797 | ||
| The autonomous notch signal pathway is activated by baicalin and baicalein but is suppressed by niclosamide in K562 cells | Q46152899 | ||
| In vitro trypanocidal activity of the anti-helminthic drug niclosamide | Q46786799 | ||
| Salicylanilides: a new group of active uncouplers of oxidative phosphorylation. | Q52471940 | ||
| [Biological-chemical mechanism of action of an anti-cestode drug N-(2'-chloro-4'-nitrophenyl)-5-chloro-salicylamide. 1. Modification of enzyme systems] | Q68453407 | ||
| Niclosamide therapy for tapeworm infections | Q70068227 | ||
| ATP depletion rather than mitochondrial depolarization mediates hepatocyte killing after metabolic inhibition | Q72101322 | ||
| The selection and use of essential medicines | Q80796505 | ||
| 6-Nitrobenzimidazole derivatives: potential phosphodiesterase inhibitors: synthesis and structure-activity relationship | Q83294987 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | niclosamide | Q418523 |
| chemotype | Q2212766 | ||
| P304 | page(s) | 1804-1816 | |
| P577 | publication date | 2017-02-03 | |
| P1433 | published in | Bioorganic & Medicinal Chemistry | Q2904200 |
| P1476 | title | Benzimidazole inhibitors from the Niclosamide chemotype inhibit Wnt/β-catenin signaling with selectivity over effects on ATP homeostasis | |
| P478 | volume | 25 |
| Q57074174 | Identification of DK419, a potent inhibitor of Wnt/β-catenin signaling and colorectal cancer growth |
| Q90519433 | Identification of novel triazole inhibitors of Wnt/β-catenin signaling based on the Niclosamide chemotype |
| Q92074696 | Investigating Monoliths (Vinyl Azlactone-co-Ethylene Dimethacrylate) as a Support for Enzymes and Drugs, for Proteomics and Drug-Target Studies |
| Q57788799 | N-substituted phenylbenzamides of the niclosamide chemotype attenuate obesity related changes in high fat diet fed mice |
| Q39227540 | Niclosamide: Beyond an antihelminthic drug |
| Q55038918 | Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer. |
Search more.